0.5(top 21%)
Impact Factor
0.5(top 21%)
extended IF
78(top 5%)
H-Index
169
authors
2K
papers
89.2K
citations
352
citing journals
1K
citing authors

Most Cited Articles of Journal of the Canadian Association of Gastroenterology

TitleYearCitations
A217 SIMETHICONE DECREASES BLOATING AND IMPROVES BOWEL PREPARATION EFFECTIVENESS: A SYSTEMATIC REVIEW AND META-ANALYSIS201978
A228 CAN SERRATED ADENOMA DETECTION RATE (SADR) BE USED TO EVALUATE THE PERFORMANCE OF CREDENTIALED SCREENING COLONOSCOPISTS IN THE NOVA SCOTIA COLON CANCER PREVENTION PROGRAM?201978
A182 ENDOSCOPIC ULTRASOUND GUIDED PANCREATIC FLUID COLLECTIONS DRAINAGE USING A LUMEN-APPOSING METAL STENT WITH ELECTRO-CAUTERY ENHANCED DELIVERY SYSTEM (HOT AXIOS); INITIAL EXPERIENCE OF A TERTIARY CARE CENTER.201978
A191 HCV SCREENING VIA RAPID POINT OF CARE TESTING IN PATIENTS ON OPIATE SUBSTITUTION THERAPY IN PEEL REGION, CANADA201978
A193 TIMELY HEPATITIS B IMMUNIZATION OF THE AT-RISK NEONATE: A QUALITY ASSURANCE REVIEW201978
A284 ROLE OF KRT15+ STEM CELLS IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA201978
A240 ANTIMICROBIAL LOCK SOLUTIONS FOR PREVENTION OF CENTRAL VENOUS CATHETER INFECTIONS IN PEDIATRIC PATIENTS WITH INTESTINAL FAILURE201978
A200 UNUSUAL PERIANAL MASS IN A CIRRHOTIC PATIENT: A CASE REPORT201978
A201 GASTRIC VARICEAL BLEED AS A FIRST PRESENTATION OF AUTOIMMUNE HEPATITIS201978
A270 EOSINOPHILIC ESOPHAGITIS IS THE LEADING CAUSE OF FOOD BOLUS IMPACTION REQUIRING ENDOSCOPY IN CALGARY, CANADA201978
A281 RISK FACTORS ASSOCIATED WITH PROGRESSION OF BARRETT’S ESOPHAGUS, LOW GRADE DYSPLASIA & HIGH GRADE DYSPLASIA TO ESOPHAGEAL ADENOCARCINOMA201978
A19 ROLE OF LGR5 IN DCLK1 POSITIVE CELL-DERIVED COLITIS-ASSOCIATED COLON CANCER201978
A26 USE OF DRUG-TOLERANT ASSAYS IN INFLAMMATORY BOWEL DISEASE; WHAT DOES IT TELL US?201978
A36 HUMAN INTERLEUKIN-4 EDUCATED MACROPHAGES SUPPRESS DNBS-INDUCED COLITIS IN MICE201978
A37 DEFECTS IN INTESTINAL MUCUS DISRUPTS THE REPERTOIRE OF DEVELOPING T CELLS IN THE THYMUS201978
A44 ELUXADOLINE FOR THE TREATMENT OF ABDOMINAL PAIN IN ADULTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME WHO REPORT INADEQUATE RESPONSE TO LOPERAMIDE201978
A55 CELL-MEDIATED DELIVERY OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) IS NEUROPROTECTIVE FOR MYENTERIC NEURONS201978
A56 ACTIVATION OF COLONIC AFFERERNT NERVES BY DEOXYCHOLIC ACID201978
A59 EXPLORING THE ROLE OF MICROBIOTA IN GASTROINTESTINAL MOTILITY201978
A81 SBF AND RAB21: TWO AUTOPHAGY REGULATORS INVOLVED IN INTESTINAL STEM CELL DIFFERENTIATION201978
A86 EXPLORING GENE-ENVIRONMENT INTERACTIONS IN CROHN’S DISEASE: THE EFFECT OF VITAMIN D DEFICIENCY ON INTESTINAL HOMEOSTASIS IN THE CONTEXT OF SUSCEPTIBILITY GENE NOD2L1007FS201978
A88 IMAGING UTILIZATION TRENDS IN IBD (1999–2016)201978
A89 EMERGING THERAPEUTIC TARGETS FOR INFLAMMATORY BOWEL DISEASE-COLORECTAL CANCER: CASE STUDY ANALYSIS201978
A105 HIGH ADHERENCE TO SURVEILLANCE GUIDELINES IN IBD RESULTS IN LOW CRC AND DYSPLASIA RATES, WHILE RATES OF DYSPLASIA AND CANCER ARE LOW BEFORE THE SUGGESTED START OF SURVEILLANCE. RESULTS FROM A TERTIARY IBD CENTER.201978
A124 IMPROVEMENT IN DISEASE ACTIVITY IS ASSOCIATED WITH LESS DISABILITY IN A PROSPECTIVE STUDY OF PEDIATRIC TRANSITION PATIENTS WITH IBD201978